West Pharmaceutical Services, Inc. (WST)

Market Cap	19.50B
Revenue (ttm)	3.02B
Net Income (ttm)	491.70M
Shares Out	71.94M
EPS (ttm)	6.75
PE Ratio	40.15
Forward PE	36.23
Dividend	$0.88 (0.32%)
Ex-Dividend Date	Nov 12, 2025

Volume	856,182
Open	276.97
Previous Close	275.34
Day's Range	268.15 - 280.80
52-Week Range	187.43 - 348.90
Beta	1.16
Analysts	Strong Buy
Price Target	354.50 (+30.79%)
Earnings Date	Oct 23, 2025

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,600
• Stock Exchange: NYSE
• Ticker Symbol: WST
• Website: https://www.westpharma.com

Financial Performance

In 2024, WST's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.

Analyst Summary

According to 9 analysts, the average rating for WST stock is "Strong Buy." The 12-month stock price target is $354.5, which is an increase of 30.79% from the latest price.

Price Target

$354.5

(30.79% upside)

Analyst Consensus: Strong Buy